Drug-Induced Glomerulonephritis
By:
Frank B. CortazarNew York Nephrology Vasculitis and Glomerular Center, Albany, New York

Search for other papers by Frank B. Cortazar in
Current site
Google Scholar
PubMed
Close
and
Reza ZonoziMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Search for other papers by Reza Zonozi in
Current site
Google Scholar
PubMed
Close
  • Collapse
  • Expand
  • 1.

    Wei SC , Duffy CR , Allison JP : Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov 8: 10691086, 2018 PubMed

  • 2.

    Larkin J , Chiarion-Sileni V , Gonzalez R , Grob JJ , Cowey CL , Lao CD , et al.: Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med 375: 2334, 20158 PubMed

    • Search Google Scholar
    • Export Citation
  • 3.

    Gandhi L , Rodríguez-Abreu D , Gadgeel S , Esteban E , Felip E , De Angelis F , et al.; KEYNOTE-189 Investigators: Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med 378: 20782092, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Motzer RJ , Tannir NM , McDermott DF , Aren Frontera O , Melichar B , Choueiri TK , et al.: Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma. N Engl J Med 378: 12771290, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Postow MA , Callahan MK , Wolchok JD Immune checkpoint blockade in cancer therapy. J Clin Oncol 33: 19741982, 2015 PubMed

  • 6.

    Postow MA , Sidlow R , Hellmann MD : Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med 378: 158168, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Perazella MA , Shirali AC Nephrotoxicity of cancer immunotherapies: Past, present and future. J Am Soc Nephrol 29: 20392052, 2018 PubMed

  • 8.

    Cortazar FB , Kibbelaar ZA , Glezerman IG , Abudayyeh A , Mamlouk O , Motwani SS , et al.: Clinical features and outcomes of immune checkpoint inhibitor-associated AKI: A multicenter study. J Am Soc Nephrol 31: 435446, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Cortazar FB , Marrone KA , Troxell ML , Ralto KM , Hoenig MP , Brahmer JR , et al.: Clinicopathologic features of acute kidney injury associated with immune checkpoint inhibitors. Kidney Int 90: 638647, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Horvat TZ , Adel NG , Dang TO , Momtaz P , Postow MA , Callahan MK , et al.: Immune-related adverse events, need for systemic immunosuppression, and effects on survival and time to treatment failure in patients with melanoma treated with ipulimumab at Memorial Sloan Kettering Cancer Center. J Clin Oncol 33: 31933198, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Weber JS , Hodi FS , Wolchok JD , Topalian SL , Schadendorf D , Larkin J , et al.: Safety profile of nivolumab monotherapy: A pooled analysis of patients with advanced melanoma. J Clin Oncol 35: 785792, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Mamlouk O , Selamet U , Machado S , Abdelrahim M , Glass WF , Tchakarov A , et al.: Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: Single-center experience. J Immunother Cancer 7: 2, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Fadel F , El Karoui K , Knebelmann B : Anti-CTLA4 antibody-induced lupus nephritis. N Engl J Med 361: 211212, 2009 PubMed

  • 14.

    Kishi S , Minato M , Saijo A , Murakami N , Tamaki M , Matsuura M , et al.: IgA nephropathy after nivolumab therapy for postoperative recurrence of lung squamous cell carcinoma. Intern Med 57 12571263, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Jung K , Zeng X , Bilusic M Nivolumab-associated acute glomerulonephritis: A case report and literature review. BMC Nephrol 17: 188, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    van den Brom RR , Abdulahad WH , Rutgers A , Kroesen BJ , Roozendaal C , de Groot DJ , et al.: Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition. Rheumatology (Oxford) 55: 11431145, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Kitchlu A , Fingrut W , Avila-Casado C , Chan CT , Crump M , Hogg D , et al.: Nephrotic syndrome with cancer immunotherapies: A report of 2 cases. Am J Kidney Dis 70: 581585, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Daanen RA , Maas RJH , Koornstra RHT , Steenbergen EJ , van Herpen CML , Willemsen AECAB : Nivolumab-associated nephrotic syndrome in a patient with renal cell carcinoma: A case report. J Immunother 40: 345348, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Estrada CC , Maldonado A , Mallipattu SK Therapeutic inhibition of VEGF signaling and associated nephrotoxicities, J Am Soc Nephrol 30: 187200, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Arnold D , Fuchs CS , Tabernero J , Ohtsu A , Zhu AX , Garon EB , et al.: Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramjcirumab.Ann Oncol 28: 29322942, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Izzedine H , Escudier B , Lhomme C , Pautier P , Rouvier P , Gueutin V , et al.: Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): An 8-year observational study at a single center. Medicine (Baltimore) 93: 333339, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22.

    Burton GJ , Redman CW , Roberts JM , Moffett A : Pre-eclampsia: pathophysiology and clinical implications. BMJ 366: l2381, 2019 PubMed

  • 23.

    Nobakht N , Nguyen HA , Kamgar MK , Abdelnour L , Rastogi A , Hanna RM Development of collapsing focal and segmental glomerulosclerosis after receiving vascular endothelial growth factor blockade. Kidney Int Rep 4: 15081512, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24.

    Nihei S , Sato J , Harada T , Kuyama S , Suzuki T , Waga N , et al.: Antiproteinuric effects of renin-angiotensin inhibitors in lung cancer patients receiving bevacizumab. Cancer Chemother Pharmacol 81: 10511059, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25.

    Hanna RM , Barsoum M , Arman F , Selamet U , Hasnain H , Kurtz I : Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: Emerging evidence.Kidney Int 96: 572580, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26.

    Avery RL , Castellarin AA , Steinle NC , Dhoot DS , Pieramici DJ , See R , et al.: Systemic pharmacokinetics and pharmacodynamics of intravitreal aflibercept, bevacizumab, and ranibizjmab. Retina 37: 18471858 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27.

    Hanna RM , Lopez EA , Hasnain H , Selamet U , Wilson J , Youssef PN , et al.: Three patients with injection of intravitreal vascular endothelial growth factor inhibitors and subsequent exacerbation of chronic proteinuria and hypertension. Clin Kidney J 12: 92100, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28.

    Touzani F , Geers C , Pozdzik A Intravitreal injection of anti-VEGF antibody induces glomerular endothelial cells injury. Case Rep Nephrol 2019: 2919080, 2019 PubMed

    • Search Google Scholar
    • Export Citation
  • 29.

    Glassman AR , Liu D , Jampol LM , Sun JK , Diabetic Retinopathy Clinical Research Network: Changes in blood pressure and urine albumin-creatinine ratio in a randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumab for diabetic macular edema. Invest Ophthalmol Vis Sci 59: 11991205, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30.

    Qin S , Li A , Yi M , Yu S , Zhang M , Wu K Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy. J Hematol Oncol 12: 27, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31.

    Liu B , Ding F , Liu Y , Xiong G , Lin T , He D , et al.: Incidence and risk of hypertension associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: A comprehensive network meta-analysis of 72 randomized controlled trials involving 30013 patients. Oncotarget 17: 6766167673, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32.

    Zhang ZF , Wang T , Liu LH , Guo HQ Risks of proteinuria associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: A systematic review and meta-analysis. PLoS One 9: e90135, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33.

    Izzedine H , Mangier M , Ory V , Zhang SY , Sendeyo K , Bouachi K , et al.: Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy. Kidney Int 85: 457470, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34.

    Arrestier R , Satie AP , Zhang SY , Plaisier E , Isnard-Bagnis C , Gatault P , et al.: Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: A retrospective study of 8 cases. BMC Nephrol 19: 331, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 35.

    Brodsky S , Eikelboom J , Hebert LA Anticoagulant-related nephropathy. J Am Soc Nephrol 29: 27872793 2009 PubMed

  • 36.

    Golbin L , Vigneau C , Touchard G , Thervet E , Halimi JM , Sawadogo T , et al.: Warfarin-related nephropathy induced by three different vitamin K antagonists: Analysis of 13 biopsy-proven cases. Clin Kidney J 10: 381388, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37.

    Brodsky SV , Satoskar A , Chen J , Nadasdy G , Eagen JW , Hamirani M , et al.: Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: A report of 9 cases. Am J Kidney Dis 54: 11211126, 2009 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38.

    Awesat J , Sagy I , Haviv YS , Rabinovich A , Jotkowitz A , Shleyfer E , et al.: Dabigatran-induced nephropathy and its successful treatment with idarucizumab: Case report and literature review. Thromb Res 169: 120122, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 39.

    Brodsky SV , Mhaskar NS , Thiruveedi S , Dhingra R , Reuben SC , Calomeni E , et al.: Acute kidney injury aggravated by treatment initiation with apixaban: Another twist of anticoagulant-related therapy. Kidney Res Clin Pract 36: 387392, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40.

    Yao X , Tangri N , Gersh BJ , Sangaralingham LR , Shah ND , Nath KA , et al.: Renal outcomes in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 70: 26212632, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 41.

    Shin JI , Luo S , Alexander GC , Inker LA , Coresh J , Chang AR , et al.: Direct oral anticoagulants and risk of acute kidney injury in patients with atrial fibrillation. J Am Coll Cardiol 71: 251252, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 42.

    Shroff GR , Stoecker R , Hart A : Non-vitamin K-dependent oral anticoagulants for nonvalvular atrial fibrillation in patients with CKD: Pragmatic considerations for the clinician. Am J Kidney Dis 72: 717727, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 43.

    Pollack CV Jr , Reilly PA , van Ryn J , Eikelboom JW , Glund S , Bernstein RA , et al.: Idarucizumab for dabigatran reversal: Full cohort analysis. N Engl J Med 377: 431441, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 44.

    Connolly SJ , Crowther M , Eikelboom JW , Gibson CM , Curnutte JT , Lawrence JH , et al.: Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N Engl J Med 380: 13261335, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 45.

    Lühe A , Künkele K-P , Haiker M , Schad K , Zihlmann C , Bauss F , et al.: Preclinical evidence for nitrogen-containing bisphosphonate inhibition of farnesyl diphosphate (FPP) synthase in the kidney: Implications for renal safety. Toxicol In Vitro 22: 899909, 2008 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 46.

    Hiroi-Furuya E , Kameda T , Hiura K , Mano H , Miyazawa K , Nakamaru Y , et al.: Etidronate (EHDP) inhibits osteoclastic-bone resorption, promotes apoptosis and disrupts actin rings in isolate-mature osteoclasts. Calcif Tissue Int 64: 219223, 1999 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 47.

    Sauter M , Jülg B , Porubsky S , Cohen C , Fischereder M , Sitter T , et al.: Nephrotic-range proteinuria following pamidronate therapy in a patient with metastatic breast cancer: mitochondrial toxicity as a pathogenetic concept? Am J Kidney Dis 47: 10751080, 2006 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 48.

    Markowitz GS , Appel GB , Fine PL , Fenves AZ , Loon NR , Jagannath S , et al.: Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 12: 11641172, 2001 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 49.

    Barri YM , Munshi NC , Sukumalchantra S , Abulezz SR , Bonsib SM , Wallach J , et al.: Podocyte injury associated glomerulopathies induced by pamidronate. Kidney Int 65: 634641, 2004 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 50.

    Desikan R , Veksler Y , Raza S , Stokes B , Sabir T , Li ZJ , et al.: Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma. Br J Haematol 119: 496499, 2002 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 51.

    Shreedhara M , Fenves AZ , Benavides D , Stone MJ : Reversibility of pamidronate-associated glomerulosclerosis. Proc Bayl Univ Med Cent 20: 249253, 2007 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 52.

    Banerjee D , Asif A , Striker L , Preston RA , Bourgoignie JJ , Roth D Short-term, high-dose pamidronate-induced acute tubular necrosis: The postulated mechanisms of bisphosphonate nephrotoxicity. Am J Kidney Dis 41: E18, 2006 PubMed

    • Search Google Scholar
    • Export Citation
  • 53.

    Smetana S , Michlin A , Rosenman E , Biro A , Boaz M , Katzir Z : Pamidronate-induced nephrotoxic tubular necrosis: A case report. Clin Nephrol 61: 6367, 2004 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 54.

    Buysschaert M , Cosyns JP , Barreto L , Jadoul M : Pamidronate-induced tubulointerstitial nephritis with Fanconi syndrome in a patient with primary hyperparathyroidism. Nephrol Dial Transplant 18: 826829, 2003 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 55.

    Markowitz GS , Fine PL , Stack JI , Kunis CL , Radhakrishnan J , Palecki W , et al.: Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int 64: 281289, 2003 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 56.

    Bodmer M , Amico P , Mihatsch MJ , Haschke M , Kummer O , Krähenbühl S , et al.: Focal segmental glomerulosclerosis associated with long-term treatment with zoledronate in a myeloma patient. Nephrol Dial Transplant 22: 23662370, 2007 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 57.

    Avguštin N , Kovač D , Kojc N , Mlinšek G , Lindič J : Acute granulomatous interstitial nephritis and acute rejection in a kidney transplant recipient after zoledronic acid therapy: A case report and review of the literature. Clin Nephrol 88: 97100, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 58.

    Anderson K , Ismaila N , Flynn PJ , Halabi S , Jaganna S , Ogaily MS , et al.: Role of bone-modifying agents in multiple myeloma: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 36: 812818, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 59.

    Berenson JR , Lichtenstein A , Porter L , Dimopoulos MA , Bordoni R , George S , et al.; Myeloma Aredia Study Group: Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. N Engl J Med 334: 488493, 1996 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 60.

    Lipton A , Theriault RL , Hortobagyi GN , Simeone J , Knight RD , Mellars K , et al.: Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: Long term follow-up of two randomized, placebo-controlled trials. Cancer 88: 10821090, 2000 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 61.

    Chang JT , Green L , Beitz J : Renal failure with the use of zoledronic acid. N Engl J Med 349: 16761679, discussion 1676–1679, 2003 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 62.

    McDermott RS , Kloth DD , Wang H , Hudes GR , Langer CJ : Impact of zoledronic acid on renal function in patients with cancer: Clinical significance and development of a predictive model. J Support Oncol 4: 524529, 2006 PubMed

    • Search Google Scholar
    • Export Citation
  • 63.

    Wilson LM , Rebholz CM , Jirru E , Liu MC , Zhang A , Gayleard J , et al.: Benefits and harms of osteoporosis medications in patients with chronic kidney disease: A systematic review and meta-analysis. Ann Intern Med 166: 649658, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 64.

    Cipriani C , Pepe J , Clementelli C , Manai R , Colangelo L , Fassino V , et al.: Effect of a single intravenous zoledronic acid administration on biomarkers of acute kidney injury (AKI) in patients with osteoporosis: A pilot study. Br J Clin Pharmacol 83: 22662273, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 65.

    Im H , Choi HM , Oh D-J , Kwon YE : Severe acute kidney injury after single-dose injection of zoledronic acid in an elderly patient. Am J Ther 25: e289e290, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 66.

    Perazella MA , Markowitz GS : Bisphosphonate nephrotoxicity. Kidney Int 74: 13851393, 2008 PubMed

  • 67.

    Raje N , Terpos E , Willenbacher W , Shimizu K , García-Sanz R , Durie B , et al.: Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: An international, double-blind, double-dummy, randomised, controlled, phase 3 study. Lancet Oncol 19: 370381, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 68.

    Markowitz GS , Bomback AS , Perazella MA : Drug-induced glomerular disease: direct cellular injury. Clin J Am Soc Nephrol 10: 12911299, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 69.

    Mérida E , Praga M : NSAIDs and nephrotic syndrome. Clin J Am Soc Nephrol 14: 12801282, 2019 PubMed

  • 70.

    Radford MG Jr , Holley KE , Grande JP , Larson TS , Wagoner RD , Donadio JV , et al.: Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs. JAMA 276: 466469, 1996 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 71.

    Beck LH Jr : PLA2R and THSD7A: Disparate paths to the same disease? J Am Soc Nephrol 28: 25792589, 2017 PubMed

  • 72.

    Sethi S , Debiec H , Madden B , Charlesworth MC , Morelle J , Gross L , et al.: Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney Int 97: 163174, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 73.

    Bakhriansyah M , Souverein PC , van den Hoogen MWF , de Boer A , Klungel OH : Risk of nephrotic syndrome for non-steroidal anti-inflammatory drug users. Clin J Am Soc Nephrol 14: 13551362, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 74.

    Pendergraft WF 3rd , Niles JL : Trojan horses: Drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol 26: 4249, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 75.

    McGrath MM , Isakova T , Rennke HG , Mottola AM , Laliberte KA , Niles JL : Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol 6: 27992805, 2011 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 76.

    Lood C , Hughes GC Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity. Rheumatology (Oxford) 56: 638643, 2017 PubMed

    • Search Google Scholar
    • Export Citation
  • 77.

    Morcos MB , Lood C , Hughes GC : Demographic, clinical, and immunologic correlates among a cohort of 50 cocaine users demonstrating antineutrophil cytoplasmic antibodies. J Rheumatol 46: 11511156, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 78.

    Collister D , Sathianathan C , Ryz K , Karpinski M , Bernstein K , Gibson IW : ANCA associated vasculitis secondary to levamisole-adultered cocaine with associated membranous nephropathy: A case series. Am J Nephrol 45: 209216, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 79.

    Moinuddin I , Madhrira M , Bracamonte E , Thajudeen B , Sussman A : Membranous nephropathy with crescents associated with levamisole-induced MPO-ANCA vasculitis. Pathol Res Pract 212: 650653, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 80.

    Carrara C , Emili S , Lin M , Alpers CE Necrotizing and crescentic glomerulonephritis with membranous nephropathy in a patient exposed to levamisole-adulterated cocaine. Clin Kidney J 9: 234238, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 81.

    Roca-Argente L , Moll-Guillen JL , Espi-Reig J , Blanes-Julia M , Garcia-Martinez AM , Pujol-Marco C , et al.: Membranous glomerulonephritis and cellular crescents induced by levamisole-adulterated cocaine abuse: A case report. Ann Transl Med 18: 271, 2015 PubMed

    • Search Google Scholar
    • Export Citation
  • 82.

    Singh V , Sharma P , Capalash N : DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer. Curr Cancer Drug Targets 13: 379399, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 83.

    Timlin H , Liebowitz JE , Jaggi K , Geetha D : Outcomes of hydralazine induced renal vasculitis. Eur J Rheumatol 5: 58, 2018 PubMed

  • 84.

    Yang J , Yao L-P , Dong M-J , Xu Q , Zhang J , Weng W-W , et al.: Clinical characteristics and outcomes of propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis in patients with Graves’ disease: A median 38-month retrospective cohort study from a single institution in China. Thyroid 27: 14691474, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 85.

    Sanchez A , Lozier M , Adkinson BC , Ilaiwy A : c-ANCA vasculitis after initiation of denosumab. BMJ Case Rep 12: e228336, 2019 PubMed

  • 86.

    Chandra T , Tabanor-Gayle J-A , Lakshminarayanan S : Adalimumab-induced anti-neutrophilic cytoplasmic antibody vasculitis: A rare complication of an increasingly common treatment. Cureus 11: e5598, 2019 PubMed

    • Search Google Scholar
    • Export Citation
  • 87.

    Hacking S , Uppal NN , Khan N , Ionescu M , Bijol V : Systemic p-ANCA vasculitis with fatal outcome, arising in the setting of methimazole use. Clin Nephrol Case Stud 7: 2326, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 88.

    Bensiradj F , Hignard M , Nakkash R , Proux A , Massy N , Kadri N , et al.: Benzylthiouracil-induced ANCA-associated vasculitis: A case report and literature review. Eur J Case Rep Intern Med 6: 001283, 2019 PubMed

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 40 40 9
Full Text Views 123 123 16
PDF Downloads 182 182 26